文献速递乳腺癌放疗放疗物理与技术

保乳放疗包括I和II站淋巴结:以肱骨头为计划危及器官的的计划研究

Elective breast radiotherapy including level I and II lymph nodes: A planning study with the humeral head as planning risk volume.
PubMed 文献 · Radiat Oncol · 2017-01-18

本研究纳入10例左侧乳腺癌患者,计划16次2.66 Gy,比较四种技术包括高位切线野(HTF)、HTF保护肱骨头、6野IMRT保护肱骨头和VMAT保护肱骨头的剂量分布。HTF对肱骨头剂量过高,保护肱骨头时HTF的PTVn V90%显著下降,而6野IMRT和VMAT的PTVn V90%分别达98.2%和99.5%,但VMAT增加肺、心脏和对侧乳腺剂量。结论:6野IMRT可在保护肱骨头的同时保证PTV覆盖且不增加OAR剂量。

要点

  • HTF对肱骨头剂量过高,V40Gy平均20.7 cc。
  • HTF保护肱骨头时PTVn V90%从97.9%显著降至89.4%。
  • 6野IMRT和VMAT的PTVn V90%分别为98.2%和99.5%。

核心结论

  • 使用HTF时很少能保护肱骨头;保护肱骨头时6野IMRT可在保证PTV覆盖的同时不增加OAR剂量。

研究设计与样本

  • 计划研究纳入10例左侧乳腺癌患者,处方为16次2.66 Gy,比较HTF、HTF保护肱骨头、6野IMRT保护肱骨头和VMAT保护肱骨头四种技术。
  • 肱骨头+10 mm通过限制V40Gy<1 cc进行保护。

主要发现

  • HTF对肱骨头的V40Gy平均为20.7 cc。
  • HTF保护肱骨头时PTVn V90%从97.9%显著降至89.4%。
  • 6野IMRT和VMAT的PTVn V90%分别为98.2%和99.5%。
  • VMAT增加肺、心脏尤其是对侧乳腺的剂量。

关键数值与推荐

  • 肱骨头保护约束为肱骨头+10 mm的V40Gy<1 cc。
  • PTVn覆盖指标为V90%,HTF为97.9%,HTF保护肱骨头为89.4%,6野IMRT为98.2%,VMAT为99.5%。

临床怎么用

  • 对于需要包括腋窝I和II站淋巴结的乳腺癌放疗,若需保护肱骨头,6野IMRT可在保证PTV覆盖的同时不增加OAR剂量。

局限性

  • 本文为计划研究,样本量10例,未报告临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to assess the dose to the humeral head planning risk volume with the currently used high tangential fields (HTF) and compare different planning techniques for breast radiotherapy including axillary level I and II lymph nodes (PTVn) while sparing the humeral head. METHODS: Ten patients with left-sided breast cancer were enrolled in a planning study with 16 fractions of 2.66 Gy. Four planning techniques were compared: HTF, HTF with sparing of the humeral head, 6-field IMRT with sparing of the humeral head and VMAT with sparing of the humeral head. The humeral head + 10 mm was spared by restricting V40Gy < 1 cc. RESULTS: The dose to the humeral head was too high with HTF (V40Gy on average 20.7 cc). When sparing the humeral head in HTF, PTVn V90% decreased significantly from 97.9% to 89.4%. 6-field IMRT and VMAT had a PTVn V90% of 98.2% and 99.5% respectively. However, dose to the lungs, heart and especially the contralateral breast increased with VMAT. CONCLUSIONS: The humeral head is rarely spared when using HTF. When sparing the humeral head, the 6-field IMRT technique leads to adequate PTV coverage while not increasing the dose to the OARs.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Surmann K, van der Leer J, Branje T, et al. Elective breast radiotherapy including level I and II lymph nodes: A planning study with the humeral head as planning risk volume. Radiat Oncol. 2017. PMID: 28100239. doi:10.1186/s13014-016-0759-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。